Références
Buvat J, Maggi M, Gooren L, et al (2010) Endocrine aspects of male sexual dysfunctions. J Sex Med 7:1627–1656
Corona G, Rastrelli G, Monami M, et al (2011) Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. Eur J Endocrinol 165:1–18
Punnen S, Cooperberg MR, Sadetsky N, Carroll PR (2001) Androgen deprivation therapy and cardiovascular risk. J Clin Oncol 29:3510–3516
Efstathiou JA, Bae K, Shipley WU, et al (2008) Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02. Eur Urol 54:816–823
Efstathiou JA, Bae K, Shipley WU, et al (2009) Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31. J Clin Oncol 27:92–99
Von Eckardstein A, Wu FCW (2004) Testosterone and cardiovascular diseases. In Nieschlag E, Behre HM (eds) Testosterone Action, Deficiency, Substitution. Cambridge University Press, Cambridge, pp 297–332
McGrath KC, McRobb LS, Heather AK (2008) Androgen therapy and atherosclerotic cardiovascular disease. Vasc Health Risk Manag 4:11–21